Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275

Benzinga Newsdesk www.benzinga.com Positive 71.3%

Neg 0% Neu 0% Pos 71.3%

Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Overweight and raises the price target from $270 to $275.